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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYPrior efforts to identify regulators of hematopoietic stem cell physiology have relied mainly on candidate gene approaches with
genetically modified mice. Here we used a genome-wide association study (GWAS) strategy with the hybrid mouse diversity panel to
identify the genetic determinants of hematopoietic stem/progenitor cell (HSPC) frequency. Among 108 strains, we observed 120- to
300-fold variation in three HSPC populations. A GWAS analysis identified several loci that were significantly associated with HSPC
frequency, including a locus on chromosome 5 harboring the homeodomain-only protein gene (Hopx). Hopx previously had been
implicated in cardiac development but was not known to influence HSPC biology. Analysis of the HSPC pool in Hopx/ mice demon-
strated significantly reduced cell frequencies and impaired engraftment in competitive repopulation assays, thus providing functional
validation of this positional candidate gene. These results demonstrate the power of GWAS in mice to identify genetic determinants
of the hematopoietic system.INTRODUCTION
In the hematopoietic stem cell (HSC) field, the identifica-
tion of regulators of HSC physiology has relied mainly on
candidate gene approaches with genetically modified
mouse models (Rossi et al., 2012). However, these studies
have not necessarily provided a complete picture of the
complex network of signals that govern HSC proliferation,
differentiation, and function. Therefore non-biased strate-
gies, such as transcriptome analyses, have been used, but
these approaches also sometimes are restricted by the
screen itself (Hope et al., 2010; Karlsson et al., 2013). For
example, many genes have been shown to be expressed
at specific differentiation stages, including the most primi-
tive HSCs (Chambers et al., 2007), but they do not provide
information as to the key regulators of HSC physiology.
An alternative unbiased strategy to elucidate the determi-
nants of HSC frequency/function is to leverage naturally
occurring variation in a forward genetics approach. In
this regard, prior studies have shown that hematopoietic
stem/progenitor cell (HSPC) frequency in mice differs as a
function of genetic background (de Haan et al., 1997),
and attempts to identify the underlying genes have em-Stemployed linkage analysis in crosses between inbred mouse
strains. For example, using the long-term culture-initiating
cell (LTC-IC; Mu¨ller-Sieburg and Riblet, 1996) or cobble-
stone area-forming cell (CAFC; de Haan and Van Zant,
1997) assays, quantitative trait loci (QTLs) for HSPC fre-
quency have been identified on chromosomes 1 and 18
among a panel of recombinant inbred (RI) strains derived
from C57Bl/6 3 DBA/2 (BXD). This strategy also has been
used to map loci for dynamic changes in CAFC frequency
associated with aging (de Haan and Van Zant, 1999; Geiger
et al., 2001).With the development of immunophenotypic
markers that could identify functional HSPCs (Morrison
and Weissman, 1994), flow cytometric analysis has been
used to identify QTLs for HSPC frequency in the BXD RI
panel, but this approach has only been successful in aged
mice (Henckaerts et al., 2002, 2004). In addition, QTLs
for HSPCs distinct from those mapped in the BXD RI panel
have been identified using different inbred mouse strains
(Morrison et al., 2002; van Os et al., 2006; Jawad et al.,
2008), suggesting that the limited variation in crosses
between two strains restricts the identification of other
genetic factors that play a role in HSPC physiology.
Furthermore, the classical QTL approach has inherentlyCell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The Authors 125
low mapping resolution, since the regions of interest typi-
cally span large chromosomal intervals and can contain
hundreds to thousands of genes. To overcome these obsta-
cles, a genetical genomics approach has been proposed,
where transcriptomics analysis is combined with QTL
mapping (deHaan et al., 2002; Bystrykh et al., 2005; Gerrits
et al., 2008). However, to date, the incorporation of inter-
mediate molecular traits into linkage analysis has led to
the identification of only one gene, latexin, where differen-
tial levels of expression influence the pool of HSPCs in the
bone marrow (BM) (Liang et al., 2007).
Genome-wide association studies (GWASs) represent
another unbiased approach that has proven particularly
successful in humans for gene discovery of numerous
disease phenotypes (Hindorff et al., 2015). Encouraged by
this success, GWASs also have been proposed in mice
using a recently developed panel of classic inbred and RI
mouse strains, termed the Hybrid Mouse Diversity Panel
(HMDP). Our prior studies with the HMDP have identified
key associations for a variety of complex traits that are
highly relevant to human diseases, which collectively illus-
trate the power of this approach for gene discovery in mice
(Bennett et al., 2010, 2012; Farber et al., 2011; Ghazalpour
et al., 2011, 2012, 2014; Park et al., 2011; Orozco et al.,
2012; Davis et al., 2013; Parks et al., 2013; Hartiala et al.,
2014). In the present study, we used this mouse platform
to carry out a comprehensive genetic screen for HSPC fre-
quency in the adult BM. We identified multiple loci associ-
ated with the frequencies of three HSPC populations and
functionally validated one positional candidate gene that
previously had not been known to play a role in the he-
matopoietic system.RESULTS
Variation in HSPC Frequencies in the HMDP
While the competitive repopulation assay is the gold stan-
dard for measuring HSPC frequency in a given population
of cells (Purton and Scadden, 2007), this method is influ-
enced by a number of parameters, including radiation
sensitivity of the host, homing and lodgment of the in-
jected cells in the BM microenvironment, and differences
in compensatory mechanisms involved in the differentia-
tion of the mature hematopoietic cells. To limit variation
due to any one or a combination of these parameters, we
chose immunophenotypic analysis to characterize the
frequency of primitive HSPC subsets in the adult BM. We
obtained BM mononuclear cells (MNCs) from 12-week-
old male mice (Table S1) and used flow cytometry to
determine the frequency of several HSPC populations.
These included Lineage[Lin]Sca-1+c-Kit+ (LSK) HSPCs,
the more immature LSKCD150CD48 multipotent pro-126 Stem Cell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The Authorgenitors (MPPs), which have been shown to be able
to differentiate into all lineages of the hematopoietic
system but have limited potential to self-renew, and
LSKCD150+CD48 cells, which are the most primitive
long-term HSCs (Kiel et al., 2008; Oguro et al., 2013). In
addition, we chose CD150 and CD48 for our analyses,
since these Slam markers have been validated to identify
the different sub-populations of HSPCs across multiple
inbred mouse strains (Kiel et al., 2005). Representative
plots that illustrate the gating strategy used for these ana-
lyses are shown in Figure S1.
Among the 108 HMDP strains screened, the frequency of
LSK, LSKCD150CD48, and LSKCD150+CD48 cells var-
ied by approximately 120- to 300-fold (Figure 1). Since all
mice were age- and sex-matched and kept under identical
environmental conditions, we attributed these differences,
at least in part, to naturally occurring genetic variation.
This notion was confirmed by calculating the heritability
for each of the three HSPC sub-populations, which yielded
values of 0.90, 0.92, and 0.70 for LSK, LSKCD150CD48,
and LSKCD150+CD48 cells, respectively. We note, how-
ever, that these heritability estimates are somewhat higher
thanwhatwould be typically expected for complex traits in
humans, since phenotype measurements in the HMDP are
obtained from multiple animals of the same genotype
(strain).
Relationship between HSPC Frequencies and Other
Hematological Parameters
We next explored the relationship between LSK,
LSKCD150CD48, and LSKCD150+CD48 cells and other
hematological parameters. The three types of primitive
HSPCs were all significantly correlated with each other
(Figure S2), with a particularly strong association between
LSK and LSKCD150CD48 cells (r = 0.70; p < 0.0001).
LSK cells exhibited modestly positive, but significant, cor-
relations with total white blood cell (WBC) count and
with the numbers of lymphocytes and monocytes (Table
S2). By comparison, LSKCD150CD48 cells were nega-
tively correlated with lymphocyte and monocyte counts
and positively associated with granulocytes. With the
exception of a weakly positive association withWBC count
and a negative relationship with mean corpuscular hemo-
globin, no correlations were observed with the most prim-
itive LSKCD150+CD48 cells. Furthermore, no significant
correlations were observed between any of the three
HSPC populations and other red blood cell (RBC) traits,
such as hemoglobin and hematocrit levels (Table S2). These
data suggest that variation in LSK and LSKCD150CD48
cells and mature WBCs could be controlled, in part, by
similar genetic mechanisms, whereas variation in
LSKCD150+CD48 cells as well as RBC parameters may be
driven by distinct factors.s
Figure 1. Variation in Three HSPC Populations in the HMDP
The frequency of LSK, LSKCD150CD48, and LSKCD150+CD48 cells exhibits 120- to 300-fold variation among 108 HMDP strains. Each dot
represents an individual mouse from the respective strain and the mean values are indicated by the horizontal black bars. BM MNCs
were isolated from the femurs and tibias of 12-week-old male mice (n = 3–8 per strain; N = 467), and the frequency of different HSPC
sub-populations was determined by flow cytometry. Data are expressed as a percentage of BM MNCs. See also Tables S1–S3 and Figures
S1 and S2.GWAS for HSPC Frequencies
To identify the genetic determinants of HSPC frequency,
we used the phenotype data to carry out a GWAS for the
three cell populations (Figures 2A–2C). One significantly
associated locus for LSKCD150+CD48 cells was identified
at the distal end of chromosome 18 (Figure 2A; Table 1),
where the lead SNP (rs36866074; p = 3.23 106)mapped to
intron 1 of the mitogen-activated protein kinase 4 (Mapk4)Stemgene (Figure 3A). On chromosome 11 (Figure 2A; Table 1),
we also identified suggestive association with an intergenic
region located 464 kb downstream of the neuromedin-U
receptor 2 (Nmur2) and507 kb upstream of the glutamate
receptor 1 isoform 1 precursor (Gria1) genes (rs29434264;
p = 2.3 3 105).
A GWAS for LSK cells revealed several suggestively associ-
ated loci, including those on chromosomes 2, 4, 6, and 18,Cell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The Authors 127
Figure 2. Manhattan Plots of GWAS
Results for HSPC Frequency in the HMDP
(A) The frequency of LSKCD150+CD48 cells
was significantly associated with a locus on
chromosome 18 harboring Mapk4 and sug-
gestively associated with a region on
chromosome 11 near Nmur2 and Gria1.
(B) A GWAS for LSK cells revealed several
suggestively associated loci on chromo-
somes 2, 4, 6, and 18 as well as a highly
significant locus on chromosome 15 con-
taining Ly6e-Ly6a-Ly6f.
(C) Three significantly associated loci on
chromosomes 1, 5, and 15 were identified in
the GWAS analysis for LSKCD150CD48
cells, as well as several suggestively asso-
ciated regions on chromosomes 3, 11, 17,
and 18. For each significantly associated
locus, the gene(s) nearest to the peak SNP
is indicated. The GWAS analyses for each of
the three HSPCs included 3–8 mice per
strain (N = 467) and 880,924 SNPs, whose
genomic positions are shown along the
x axis with their corresponding log10
p values indicated by the y axis. The
genome-wide thresholds for significant (p =
4.1 3 106) and suggestive (p = 4.1 3
104) evidence of association are indicated
by the horizontal red and blue lines,
respectively.
See also Figure S3.
128 Stem Cell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The Authors
Table 1. Loci Identified in GWAS for HSPCs in the HMDP
HSPC Population Chromosome Position (bp)a Lead SNP Nearest Gene(s) Minor Allele Frequency p Value p Valueb
LSKCD150+CD48 11 56318423 rs29434264 Nmur2-Gria1 0.06 2.3 3 105 NA
18 74202262 rs36866074 Mapk4 0.13 3.2 3 106 NA
LSK 15 75203270 rs31675052 Ly6e-Ly6a-Ly6f 0.47 3.7 3 1014 NA
18 14494409 rs30267408 Zfp521-Ss18 0.41 4.3 3 104 9.4 3 106
LSKCD150CD48 1 173168046 rs8242728 Ndufs2-Cd48-Slamf1 0.50 9.3 3 1010 4.4 3 1012
5 77528483 rs29633853 Hopx 0.15 5.1 3 107 1.1 3 106
15 74669094 rs32350275 Ly6e-Ly6a-Ly6f 0.40 3.0 3 107 NA
18 14474199 rs31073841 Zfp521-Ss18 0.11 3.8 3 104 5.7 3 105
NA, not applicable.
aBase pair position of lead SNP given according to NCBI build 37 of the reference mouse genome sequence.
bp value obtained from GWAS analysis that excluded strains carrying the uninformative haplotype of Sca-1 at the chromosome 15 locus. See also Figures
S3 and S4.as well as a highly significant (p = 3.7 3 1014) locus on
chromosome 15 (Figure 2B; Table 1), where the lead SNP
(rs31675052) is located approximately 100 kb downstream
of Ly6f (Figure 3B). Ly6f is part of a family of genes located
at this locus that encode Sca-1, which is one of the surface
markers used to immunophenotypically quantitate HSPC
frequency. While Sca-1 is known to play a role in the func-
tion ofHSPCs (Ito et al., 2003), some studies have suggested
that it is not an informative cell surface marker for flow cy-
tometry analysis in certain mouse strains (Spangrude and
Brooks, 1993). To address this potential issue and remove
the effect of the chromosome 15 locus, we re-performed
the GWAS analysis after excluding strains carrying the
low Sca-1-expressing haplotype (Table S1). Importantly,
exclusion of these strains did not appreciably decrease
the heritability for variation in LSK cells (0.90 versus
0.82). Furthermore, the Sca-1 locus did not yield an associ-
ation signal in this analysis, as expected, but the suggestive
peak on chromosome 18 increased in significance from p =
4.3 3 104 to just below the threshold for genome-wide
significance with p = 9.4 3 106 (Table 1; Figure S3A).
The peak SNP (rs30267408) on chromosome 18 is not
located within a known gene, but it maps 363 kb distal
to the zinc-finger protein 521 (Zfp521) and 290 kb prox-
imal to the synovial sarcoma-associated Ss18-alpha (Ss18)
genes (Figure S3B).
We next performed a GWAS for LSKCD150CD48
cells and identified three significantly associated loci
on chromosomes 1 (rs8242728; p = 9.3 3 1010),
5 (rs29633853; p = 5.1 3 107), and 15 (rs32350275;
p = 3.0 3 107), as well as several suggestively associated
loci on chromosomes 3, 11, 17, and 18 (Figure 2C; Table
1). Since the chromosome 15 locus for LSKCD150CD48Stemcells was the same as that identified for LSKs, we re-
performed the GWAS after excluding the same strains car-
rying the low Sca-1-expressing haplotype. Similar to LSK
cells, excluding these strains only had a marginal effect
on the heritability of LSKCD150CD48 cells (0.92 versus
0.88). This analysis strengthened the association signal on
chromosome 1 (p = 4.4 3 1012), but had no effect on
chromosome 5 (p = 1.1 3 106) nor revealed any
additional regions associated with LSKCD150CD48
cells (Table 1; Figure S4A). The lead SNP on chromosome
1 (rs8242728) fell within a large 2-Mb linkage disequilib-
rium (LD) block containing dozens of genes and
numerous SNPs that yielded equivalently significant
p values (Figure 3C). Given this LD pattern, it would be
difficult to narrow down the underlying causative gene
without extensive follow-up. For example, rs8242728 is
specifically located within the NADH dehydrogenase
[ubiquinone] iron-sulfur protein 2 (Ndufs2) gene. How-
ever, this interval also encompasses the Slam locus and
contains the Cd48 and Slamf1 genes, which encode two
of the other flow cytometry markers used for quantitating
HSPCs (CD48 and CD150). By comparison, the most
significantly associated SNPs on chromosome 5 are
located within a small LD block, with the peak SNP
(rs29633853) localizing to the homeodomain-only pro-
tein (Hopx) gene (Figure 3D). Interestingly, the sugges-
tive association with the peak SNP on chromosome 18
(rs31073841), which maps 20 kb proximal to the peak
SNP of the same Zfp521-Ss18 locus identified for LSKs,
also increased in significance by nearly one order of
magnitude from p = 3.8 3 104 to p = 5.7 3 105 after
exclusion of the strains carrying the low Sca-1-expressing
haplotype (Table 1; Figure S4A). This observation suggestsCell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The Authors 129
Figure 3. Regional Plots of Loci Significantly Associated with HSPCs in the HMDP
(A) The lead SNP at the chromosome 18 locus for LSKCD150+CD48 cells (rs36866074) maps to intron 1 of Mapk4 (boxed in red).
(B) The lead SNP on chromosome 15 for LSKs (rs31675052) maps to a region harboring Ly6e, Ly6a, and Ly6f (boxed in red), which are part of
a family of genes at this locus that encode one of the surface markers used to immunophenotypically quantitate HSPC frequency (Sca-1).
(C) The chromosome 1 locus identified for LSKCD150CD48 cells encompasses a large 2-Mb LD block containing dozens of genes and
numerous SNPs that yielded equivalently significant p values. Although the lead SNP (rs8242728) is specifically located in Ndufs2 (boxed
in red), this interval also includes Cd48 and Slamf1 (boxed in red), which encode two of other flow cytometry markers used for quantitating
HSPCs (CD48 and CD150).
(D) The peak SNP at the chromosome 5 locus (rs29633853) associated with LSKCD150CD48 cells is located within a small LD block and
localizes to Hopx (boxed in red). For each plot, a 1–2-Mb region is shown and the lead SNP is indicated by a red diamond.
(A–D) (Top) SNP positions are shown on the x axis with their correspondinglog10 p values indicated by the y axis. (Bottom) The locations
of genes in the selected intervals are given. See also Figure S4.that this chromosome 18 locus may exert pleiotropic
effects on multiple HSPC subsets.
Prioritization of Positional Candidate Genes at
Chromosome 5 Locus for LSKCD150CD48
Frequency
Of the loci identified, we focused on the chromosome 5
locus because of the increased mapping resolution and
the possibility that this region contains a previously un-
known gene(s) for LSKCD150CD48 cells. In particular,
rs29633853 is located within intron 1 of Hopx, which has
been shown to play important roles in cardiac develop-
ment (Chen et al., 2002; Shin et al., 2002) and lymphoid
regulation (Albrecht et al., 2010) and to serve as a marker130 Stem Cell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The Authorfor quiescent intestinal epithelial stem cells (Takeda et al.,
2011) and multipotent hair follicle stem cells (Takeda
et al., 2013). However, Hopx has otherwise not been impli-
cated in the biological regulation of HSPCs. To evaluate
Hopx as a positional candidate, we first searched the pub-
licly available genomic sequences of 60 inbred mouse
strains, but we did not identify any amino acid substitu-
tions and/or other protein structure-altering variations.
We next used gene expression data across multiple tissues
in the HMDP (http://geneeqtl.genetics.ucla.edu/) to deter-
mine whether the chromosome 5 locus exhibited any cis
expression QTL (eQTL), defined as those mapping within
a 2-Mb interval centered on the lead GWAS SNP
(rs29633853). Of the 20 genes in this region (Figure 3D),s
Table 2. Genes Exhibiting cis eQTLs across Multiple Tissues at the Chromosome 5 Locus for LSKCD150CD48 Cells
Gene Gene Position (bp)a SNP SNP Position (bp)a GWAS p Valueb
eQTL p Value
Bone Macrophage Liver Heart
Srd5a3 76569296-76584529 rs13478330 75857166 0.26 5.8 3 107 ns ns ns
rs3153753 76574923 0.99 4.0 3 1015 ns ns ns
rs4225290 76583956 0.76 ns ns ns 5.0 3 108
rs33559924 76254389 0.47 ns ns 9.0 3 1012 ns
rs3697530 76575062 0.82 ns ns 3.9 3 1016 ns
rs13478335 76955455 0.41 ns 2.0 3 1017 ns ns
Tmem165 76612905-76638270 rs4225290 76583956 0.76 ns 1.5 3 1011 ns ns
Exoc1 76958336-76999319 rs4225290 76583956 0.76 9.4 3 1010 ns ns ns
rs13478334 76817411 0.64 ns 9.4 3 1012 ns ns
rs33139946 76913636 0.64 ns 9.4 3 1012 ns ns
rs31555016 76915601 0.64 ns 9.4 3 1012 ns ns
rs31555860 76921199 0.64 ns 9.4 3 1012 ns ns
rs29561143 77013954 0.86 ns ns 5.2 3 107 ns
Cep135 77075352-77075401 rs29824030 75977692 0.36 6.2 3 108 ns ns ns
rs13478331 76154830 0.38 1.7 3 109 ns ns ns
Hopx 77516011-77544181 rs33077631 77509306 6.1 3 106 4.0 3 108 ns ns ns
rs33175967 77511463 2.6 3 105 ns ns ns 6.2 3 1019
rs33750358 77534348 6.1 3 106 4.0 3 108 ns ns ns
rs33117479 77536186 4.8 3 105 ns 1.6 3 106 3.4 3 1018 ns
A genomic region ±1 Mb around the peak SNP for LSKCD150CD48 cells on chromosome 5 (rs29633853; bp position 77528483) was interrogated for the
presence of cis eQTLs in multiple tissues using the UCLA Systems Genetics Resource (http://systems.genetics.ucla.edu/). Only genes exhibiting cis eQTLs in
bone, macrophage, liver, or heart are listed. Ns, not significant.
aBase pair (bp) positions of genes and SNPs are given according to NCBI build 37 of the reference mouse genome sequence.
bp values are given from GWAS results that included all HMDP strains. See also Figure S4.Srd5a3, Tmem165, Exoc1, Cep135, and Hopx exhibited cis
eQTLs in either bone, macrophages, liver, or heart (Table
2). However, only variants in Hopx yielded both significant
associations with LSKCD150CD48 cells and cis eQTLs
across all four tissues examined. In particular, the lead
eQTL SNP in liver (rs33117479; p = 3.43 1018) was located
8 kb proximal to the lead SNP for LSKCD150CD48 cells
(rs29633853), whereas the lead eQTL SNP in heart
(rs33175967; p = 6.2 3 1019) was 17 kb distal. The over-
lap between the association signals for LSKCD150CD48
frequency and hepatic HopxmRNA expression at the chro-
mosome 5 locus is illustrated in Figure S4B.
To further evaluate whetherHopx plays a role in the regu-
lation of HSPCs, we performed gene expression analysis by
RT-PCR in BM MNCs of 25 different mouse strains with
varying LSKCD150CD48 frequencies. These analysesStemdemonstrated that Hopx was expressed in BM and that its
mRNA levels were both variable and correlated (r = 0.44)
with LSKCD150CD48 frequency in these strains (Fig-
ure 4A). This latter observation is not entirely surprising
since the coincident mapping of cis eQTLs for Hopx across
multiple tissues and LSKCD150CD48 frequency to the
same chromosome 5 could be expected to result in a corre-
lation between Hopx gene expression and cell number in
BM. We next purified various HSPC subsets and other
hematopoietic-derived lineages from C57BL/6 mice and
determined the cell-specific expression pattern of Hopx.
These analyses revealed that Hopx was expressed in all he-
matopoietic cells and at particularly high levels in mature
hematopoietic lineages, such as CD3+ T lymphocytes (Fig-
ure 4B). To confirm these findings, we used flow cytometry
to analyze BM of genetically modified mice that expressCell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The Authors 131
Figure 4. Relationship between Hopx
Gene Expression and HSPCs
(A) Among 25 HMDP strains, Hopx expres-
sion levels in BM MNCs are positively
correlated (r = 0.44) with LSKCD150CD48
frequency. Each data point represents the
mean expression of each mouse strain (n =
2–3 mice/strain) across two independent
experiments. LSKCD150CD48frequency is
expressed as a percentage of BM MNCs and
expression levels are shown relative to the
expression of Hprt, as an endogenous con-
trol, in relative units (ru).
(B) Hopx is expressed in various hemato-
poietic cell subsets of C57Bl/6 mice (n = 3),
including all three HSPC populations, but at
very low levels in mesenchymal stem cells
(MSCs). Expression is also abundant in
mature leukocytes, particularly in T lym-
phocytes (CD3+) compared with B lympho-
cytes (B220+) or monocytes (CD11b+). Total
RNA was isolated from BM and RT-PCR was
carried out as described in the Experimental
Procedures. Expression levels are shown
relative to the expression of Hprt, as an endogenous control, in relative units (ru) with error bars representing SEM.
(C) As determined by relative GFP fluorescence intensity, Hopx expression was highest in the LSKCD150CD48 population of HSPCs and
especially abundant in CD3+ cells, consistent with the RT-PCR results. Fluorescence was quantitated by flow cytometry in different HSPC
sub-populations and mature hematopoietic lineages in BM MNCs that were isolated from the femurs and tibias of 12-week-old genetically
modified mice (n = 3) expressing GFP under the control of the endogenous Hopx promoter (Takeda et al., 2013). Data are expressed in a.u.
Note the different x axes in the plots.GFP under the control of the endogenous Hopx promoter
(Takeda et al., 2013). As shown in Figure 4C, Hopx was ex-
pressed highest in the LSKCD150CD48 population of
HSPCs and in CD3+ cells, which is consistent with the
RT-PCR results. Collectively, these data point to Hopx as a
strong positional candidate gene since (1) genetic variation
at this locus is functional with respect toHopx gene expres-
sion in multiple tissues, (2) mRNA levels of Hopx in BM
MNCs are positively associated with LSKCD150CD48
number, and (3) Hopx is expressed at relatively high levels
in the HSPC subset whose frequency maps to the chromo-
some 5 locus.
Biological Validation of Hopx as a Gene that Regulates
LSKCD150CD48 Cells
To biologically validate Hopx as a genetic determinant of
HSPCs, we characterized previously generated Hopx
knockout (Hopx/) mice (Chen et al., 2002) for differ-
ences in HSPC frequency and function. Flow cytometric
analysis revealed that Hopx/ mice had significantly
reduced numbers of LSKCD150CD48 cells compared to
wild-type Hopx+/+ littermates, but no differences in the
frequency of LSK (Figure 5A) or LSKCD150+CD48
cells (data not shown). Since the reduced frequency of132 Stem Cell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The AuthorLSKCD150CD48cells in Hopx/ mice could be due to
either intrinsic defects of the cells or extrinsic factors, we
performed competitive repopulation assays with HSCs
from Hopx/ mice and wild-type littermates. These exper-
iments demonstrated that transplantation of HSCs from
Hopx/ mice did not affect levels of circulating CD45.2
cells at early time points, but led to significantly impaired
engraftment at 16 weeks after transplantation and extend-
ing to 24weeks (Figure 5B). However, analysis ofmulti-line-
age engraftment in these mice did not reveal significant
differences in the relative abundance of circulating B lym-
phocytes, T lymphocytes, or myeloid cells (Figure S5).
We next analyzed the composition of BM MNCs at
the 24-week time point. Compared to transplantation
with Hopx+/+ HSCs, mice transplanted with HSCs from
Hopx/ mice had a significant and specific reduction
in the frequency of LSKCD150CD48 cells, but not
LSK (Figure 5C) or LSKCD150+CD48 cells (data not
shown). To investigate a potential biological mechanism
for the functional effects of Hopx deficiency on HSPC
frequency, we analyzed the cell-cycle status of LSK and
LSKCD150CD48 cells. Hopx/ mice had signifi-
cantly reduced numbers of quiescent LSKCD150CD48
cells and increased numbers of cells in the G1 phases
Figure 5. Functional Validation of the Effects of Hopx on HSPC Physiology
(A) The frequency of LSKCD150CD48 cells, as a percentage of BM MNCs (left y axis), are significantly reduced in Hopx/mice compared
to wild-type littermate controls (Hopx+/+), whereas LSKs are not affected (right y axis). BMMNCs were isolated from the femurs and tibias of
12-week-old male mice and the frequency of different HSPC sub-populations was determined by flow cytometry.
(B) Competitive repopulation assay shows significantly decreased levels of engraftment starting at 16 weeks after transplantation of HSCs
isolated from BM of Hopx/ mice compared to wild-type Hopx+/+ littermates. Mice were bled from the tail vein every 4 weeks after
transplantation and the level of engraftment, indicated by the percentage of circulating CD45.2+ cells, was quantified by flow cytometry.
(C) Frequency of LSKCD150CD48 cells in BM, as a percentage of MNCs (left y axis), is significantly reduced in mice transplanted with HSCs
from Hopx/mice compared to Hopx+/+ littermate controls 6 months following transplantation. There is no difference in the frequency of
LSKs (right y axis).
(D) LSKCD150CD48 cells of Hopx/ mice exhibit altered cell-cycle status, with decreased and increased percentage of cells in the
G0 and G1 phases, respectively, compared to wild-type littermates. No effects were observed in LSKs.
For each experiment in (A)–(D), error bars represent SEM and n = 3–5 mice per group. *p < 0.05; **p < 0.01. See also Figure S5.(Figure 5D). However, Hopx deficiency had no cell-cycle
effects on LSKs (Figure 5D) or LSKCD150+CD48 cells
(data not shown). Taken together, these data validate
the GWAS findings and provide functional evidence that
Hopx is a positive regulator of HSPC frequency in mice.DISCUSSION
In the present study, we carried out a phenotypic screen
with over 100 inbred strains from the HMDP to investigate
how the frequency of three HSPC populations varies as a
function of naturally occurring genetic variation. The re-
sults revealed substantial variability across this panel of
mouse strains, at least based on the specific cell surfaceStemmarkers we used to quantify cell number. However, this
may not necessarily reflect the true variation in the pool
size of all stem cells, since, for example, the number of
HSPCs in strains carrying the Sca-1 null allele could be
underestimated. Despite this possibility, we still observed
relatively strong correlations between certain HSPC sub-
sets, but, interestingly, not betweenHSPCs and the number
of circulating mature blood cells or other hematological
parameters.
Using the strain survey data, we also carried out a
GWAS analysis and identified multiple distinct and
overlapping loci that were significantly or suggestively
associated with HSPC sub-populations. At one particular
locus on chromosome 5, we provide strong evidence
that LSKCD150CD48 cell frequency and function isCell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The Authors 133
regulated by Hopx, a gene that was previously not known
to influence HSPC biology. The collective results of the
functional validation studies with Hopx/ mice and
competitive transplantation assays demonstrated that
Hopx deficiency led to a specific and intrinsic functional
defect in the MPP subset of HSCs (LSKCD150CD48),
possibly related to cell-cycle status, but not in the most
primitive long-term subset of cells or more committed pro-
genitor populations. These observations were also entirely
consistent with the gene expression analyses, showing that
Hopx mRNA levels in the BM were positively correlated
with LSKCD150CD48 cells, and theGWAS results, where
the Hopx locus was only associated with this HSPC subset
and not with LSKs or LSKCD150+CD48 cells. Of direct
relevance to our findings, a recent study demonstrated
how different HSC populations, and LSKCD150CD48
cells in particular, play distinct temporal roles in the main-
tenance of the hematopoietic system (Busch et al., 2015).
More specifically, it is the LSKCD150CD48 sub-popula-
tion of cells that sustains adult hematopoiesis under
homeostatic conditions through multiple rounds of self-
renewal. Furthermore, proliferation of this cell population
accounts for the differentiation of committed progenitors,
while only receiving limited input from themore primitive
LSKCD150+CD48 sub-population of cells.
Hopx is a homeodomain-only protein that lacks DNA-
binding activity yet is predominantly localized to the
nucleus (Chen et al., 2002; Shin et al., 2002). There are
many different functional roles proposed for this protein
depending on the cell type examined. Through direct pro-
tein-protein interactions, Hopx was shown to repress the
expression of serum response factor (SRF)-dependent genes
(Kook and Epstein, 2003), and conditional deletion of Srf in
mouse BM leads to an approximate 3-fold increase in the
frequency of all HSPC sub-populations (Ragu et al., 2010).
Therefore, one plausible mechanism for why Hopx defi-
ciency leads to decreased numbers of LSKCD150CD48
cells could be as a result of increased Srf-mediated transcrip-
tion of downstream targets. Alternatively, Hopx may affect
HSPC frequency through its effects on cell-cycle status. For
example, we demonstrated that Hopx/ mice have a
decreased proportion of LSKCD150CD48 cells in the
quiescent G0 state and increased numbers in the G1 phase.
Other groups have shown thatHopx promotermethylation
frequently is observed in many malignancies, including
esophageal, gastric, pancreatic, and colorectal cancers,
where it has been suggested thatHopx functions as a tumor
suppressor gene (Yamashita et al., 2013). Since it is known
that deficiency of a number of genes in the hematopoietic
system leads to increased entry into cell cycle, with a conse-
quent loss of HSPC frequency and function (Orford and
Scadden, 2008), it is possible that perturbation of Hopx
expression/activity affects the intrinsic homeostasis of134 Stem Cell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The AuthorHSPCs by altering cellular quiescence and, thus, cell
frequency.
Two other interesting observations from our GWAS
results were the overlap of loci that previously had been
mapped for HSPC phenotypes using linkage analysis and
identification of genomic regions that harbored genes en-
coding cell surface markers used for flow cytometry. In
this regard, we identified a major locus for LSK cells over
the genes encoding Sca-1 (Ly6e-Ly6a-Ly6f) on chromosome
15, which confirms previous reports that certain strains
carry a Sca-1 haplotype associated with decreased expres-
sion (Spangrude and Brooks, 1993). Exclusion of these
strains from the analysis did not significantly decrease
the heritability of LSK variation or reveal additional loci,
but yielded highly suggestive evidence for association
with a chromosome 18 locus containing Zfp521. QTL anal-
ysis with BXD RI strains also identified a locus for HSC fre-
quency on chromosome 18 nearZfp521, although the peak
of that linkage signal mapped 20 Mb distal from our lead
GWAS SNP (de Haan and Van Zant, 1997). Zfp521 encodes
a transcription factor protein with 30 zinc fingers that was
originally identified as being specifically expressed in
primitive human CD34+ cells compared to more mature
hematopoietic cells (Bond et al., 2004). More recently,
Zfp521 also has been implicated in bone formation (Hesse
et al., 2010; Kiviranta et al., 2013), but validation of Zfp521
as a gene directly influencing HSPCs will require additional
functional studies. Notably, the loci on chromosomes
15 (Ly6e-Ly6a-Ly6f) and 18 (Zfp521-Ss18) were identified
in the GWAS analyses for LSKCD150CD48 cells as well.
However, aside from these two regions, there was no
overlap between the loci identified for the three HSPC
populations or with those previously reported for blood
cell traits in the HMDP (Davis et al., 2013). In addition to
Ly6e-Ly6e-Ly6f, our GWAS analysis revealed highly signifi-
cant association of LSKCD150CD48 cells with the Slam
locus on chromosome 1, the strength of which increased
by two orders of magnitude after excluding the low Sca-
1-expressing strains. Consistent with our results, Mu¨ller-
Sieburg and Riblet (1996) also mapped a QTL for HSCs
directly over the Slam locus using the CAFC assay and link-
age analysis in the BXD RI panel. Although we cannot
determine with certainty whether Cd48 and Slamf1 ac-
count for the signal on chromosome 1 due to extensive
LD across this region, Cd48-deficient mice do exhibit
increased numbers of short-term HSCs (Boles et al., 2011).
While GWAS in humans has been successful in identi-
fying genes for many different disease phenotypes, these
types of analysis have had limited success for HSPCs. This
is due, in part, to the logistical challenges of obtaining the
relevant tissue in humans (i.e., BM) in large numbers of
subjects in order to have sufficient mapping power. For
example, a GWAS in the FraminghamHeart Study for levelss
of circulating CD34+ cells only identified suggestive loci,
none of which could be functionally validated (Cohen
et al., 2013). With respect to the present results, the rele-
vance of the identified genes and pathways to humans is
still tobedetermined.However, it is encouraging that recent
studies in the HMDP were able to directly correlate mouse
association signals with those identified in human GWAS
(Davis et al., 2013; Parks et al., 2013). For instance, four of
the five loci identified for RBC parameters in the HMDP
(Davis et al., 2013) correspond to loci recently reported for
analogous phenotypes in a large human GWAS (van der
Harst et al., 2012). These observations reinforce the concept
that the underlying biological pathways for complex traits
are likely to be conserved between mice and humans.
In summary, we demonstrate the power of the HMDP as
a platform to identify the genetic determinants of highly
relevant biomedical traits that would otherwise not
be feasible or logistically challenging to investigate in
humans. While our studies only investigated the genetic
determinants of HSPC frequency in the adult BM, they pro-
vide a proof of principle that similar unbiased approaches
can be applied to comparable ormore complex phenotypes
in other stem cell systems. Such gene discovery efforts may
lead to targets that could be studied toward further under-
standing the biological regulation of stem cells and/or
manipulated for therapeutic development.EXPERIMENTAL PROCEDURES
Animals
The 12-week-oldmalemice of 108 inbred strains (n = 3–8) from the
HMDP were obtained (The Jackson Laboratory) and used in accor-
dance with the USC Institutional Animal Care andUse Committee
guidelines. Mice were maintained on a 12-hr light/dark cycle in
sterilized microisolator cages and received autoclaved food and
water ad libitum. Biological validation of Hopx was carried out
using previously generated genetically targeted mice (Chen et al.,
2002; Takeda et al., 2013).
Flow Cytometry
BM MNCs were incubated in PBS with fluorescent labeled anti-
mouse antibodies. The labeled cells were then analyzed by flow
cytometry using an LSR II flow cytometer (Becton Dickinson), and
HSPC frequencies were calculated according to established cell im-
munophenotypes using FlowJo flow cytometry analysis software.
Figure S1 illustrates the gating strategy used for the flow cytometry
analyses in selected mouse strains that were chosen to represent
the range of variation in HSPC frequency. Details regarding the
flow cytometric analyses are described in the Supplemental Experi-
mentalProcedures anda listof all antibodiesused isgiven inTableS3.
Complete Blood Count Analysis
Mice (n = 3/strain) were fasted for 4–5 hr and bled from the
retro-orbital plexus under isoflurane anesthesia 2–3 hr after theStembeginning of the light cycle. Blood was collected in 20-ml EDTA-
coated glass capillaries, processed using standard procedures, and
profiled with respect to hematological parameters using the Heska
HemaTrue Veterinary Hematology Analyzer, as described previ-
ously (Davis et al., 2013).
Statistical Genetics Analysis
GWAS analyses utilized 880,000 genotyped and imputed SNPs
and implemented an efficient mixed model algorithm (EMMA)
that takes into account the underlying population structure and
genetic relatedness across the strains, as described previously
(Kang et al., 2008; Bennett et al., 2010). Details regarding the statis-
tical genetics methodology are described in the Supplemental
Experimental Procedures.
Gene Expression Analysis
Total RNAwas extracted using RNAMiniprep Kits (Stratagene) and
was reverse-transcribed into cDNA using SuperScript VILO cDNA
synthesis kits (Invitrogen). Taqman gene expression assay primers
and probe sets (Applied Biosystems and Roche Diagnostics) were
used to quantify expression of Hopx (assay ID Mm00558630_m1)
and Hprt (assay ID Mm01545399_m1) as an endogenous control.
Gene expression levels were measured in triplicate using a
7900HT real-time PCR system (Applied Biosystems). Standard
curves in these experiments were created with the use of qPCR
mouse reference total RNA (Stratagene).
Competitive Repopulation Assays
BM MNCs were obtained from Hopx+/+ and Hopx/ mice and the
primitive LSKCD150+CD48 HSCs were isolated using cell
sorting. To quantify the ability to reconstitute hematopoiesis,
100 LSKCD150+CD48 cells from Hopx+/+ or Hopx/ mice, along
with 250,000 competitor BM MNCs from a B6.SJL congenic
mouse, were injected into the tail veins of B6.SJL mice that were
lethally irradiated with 9 Gy approximately 24 hr prior to trans-
plantation. Peripheral blood samples were obtained from the tail
vein of hosts starting at 4 weeks after transplantation and every
4 weeks thereafter, for a total of 24 weeks. PE anti-mouse
CD45.1, fluorescein isothiocyanate (FITC) anti-mouse CD45.2,
APC anti-mouse CD3e, APC-Cy7 anti-mouse CD11b, and bio-
tinylated anti-mouse B220 antibodies (all from Becton Dickinson)
were used to assess the degree of multi-lineage reconstitution.
Cell-Cycle Experiments
For cell-cycle analysis, cells were incubated with 10 mg/ml Hoechst
33342 (Sigma-Aldrich) at37Cfor45min, thenstainedwith lineage
and stem cell antibodies as described above. The stained cells were
resuspended and fixed in 10% buffered formalin and incubated at
4C overnight. To stain for RNA content, pyronin Y (Polysciences)
was added to the cells at a final concentration of 0.75 mg/ml and
incubated at 4C for 30 min. Cell-cycle status was examined using
an LSR II flow cytometer (Becton Dickinson) and FlowJo software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experi-
mental Procedures, five figures, and three tables and can beCell Reports j Vol. 5 j 125–138 j July 14, 2015 j ª2015 The Authors 135
found with this article online at http://dx.doi.org/10.1016/j.
stemcr.2015.05.008.
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